In cancer cells, SP (via the NK-1R) increases the concentration of intracellular Ca++ (Figure 1), induces the breakdown of glycogen and then, due to the glucose obtained, these cells increase their metabolism; however, NK-1R antagonists block such a breakdown and cancer cells die from starvation [60]. Here, TACR1 is linked to cancer.